Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Minnesota News
The Associated Press
St. Paul

Minnesota not among states settling with Purdue Pharma

Prescription bottles placed on the sidewalk.
In this Aug. 17, 2018, file photo, family and friends who have lost loved ones to OxyContin and opioid overdoses leave pill bottles in protest outside the headquarters of Purdue Pharma, which is owned by the Sackler family, in Stamford, Conn. Minnesota Attorney General Keith Ellison says the state is not among those that have reached a tentative settlement with OxyContin maker Purdue Pharma over the opioids epidemic.
Jessica Hill | AP

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Minnesota Attorney General Keith Ellison says the state is not among those that have reached a tentative settlement with OxyContin maker Purdue Pharma over the opioids epidemic.

The tentative deal between Purdue, thousands of local governments and more than 20 states could be worth up to $12 billion over time. Purdue has been criticized for overselling the benefits of its powerful prescription opioid painkillers and understating the risks.

Ellison says he feels there's uncertainty about the details of the agreement, including the amount of payments, the time period over which the payments would be made and terms for ownership and operation of Purdue and other holdings.

One of the next steps for Pharma is a bankruptcy filing, which would likely end lawsuits filed against the company. Parities that don't agreed to settle could raise objections in bankruptcy court.